Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |